This inventor holds 5 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Cytokinetics, Inc., Amgen Inc.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: The Innovative Contributions of Mingda Bi
Introduction
Mingda Bi is a prominent inventor based in Simi Valley, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on heterocyclic compounds. With a total of 5 patents to his name, Bi has established himself as a key figure in the industry.
Latest Patents
Among his latest patents, Bi has developed formulations of omecamtiv mecarbil, which include methods for their preparation and use. These patents focus on the pharmaceutical applications of heterocyclic compounds, showcasing his expertise in creating effective medical solutions.
Career Highlights
Throughout his career, Mingda Bi has worked with notable companies such as Cytokinetics, Inc. and Amgen Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical sector.
Collaborations
Bi has collaborated with talented individuals in his field, including Robert Kuehl and Fernando Alvarez-Nunez. These partnerships have further enhanced his innovative capabilities and have led to the development of impactful pharmaceutical products.
Conclusion
Mingda Bi's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to influence the development of new medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile